Carboxypeptidase A6 in zebrafish development and implications for VIth cranial nerve pathfinding

Area of Science:

• Developmental Biology
• Neuroscience
• Biochemistry

Background:

• Carboxypeptidase A6 (CPA6) is an extracellular protease linked to Duane syndrome.
• Its role in axon guidance and cranial nerve development is not fully understood.

Purpose of the Study:

• To investigate the role of zebrafish Carboxypeptidase A6 (CPA6) in embryonic development and axon guidance.
• To determine if CPA6 deficiency impacts VIth cranial nerve development and function in zebrafish.

Main Methods:

• Identified and cloned the zebrafish ortholog of CPA6.
• Characterized zebrafish CPA6 secretion, extracellular matrix interaction, pH optimum, and substrate specificity.
• Analyzed CPA6 mRNA expression patterns during zebrafish development.
• Utilized morpholino-mediated knockdown of CPA6, retrograde labeling, and horizontal eye movement analysis.

Main Results:

• Zebrafish CPA6 is a secreted protease with neutral pH optimum and specificity for hydrophobic amino acids.
• CPA6 expression was observed in chondrogenic sites, including those forming the lateral rectus muscle myodome.
• Morpholino-mediated knockdown of CPA6 did not affect VIth nerve development or function in zebrafish.

Conclusions:

• CPA6 deficiency alone is insufficient to cause VIth nerve developmental defects in zebrafish.
• Altered VIth nerve pathfinding in Duane syndrome may involve CPA6 in conjunction with other genetic or regulatory factors.
• Duane syndrome could potentially arise from chondrogenic developmental disruptions rather than solely myogenic or neurogenic issues.